CLASS II Device recall · Reported 3 Jan 2018 · FDA Enforcement Report

Vitros Chemistry Products Phyt Slides recalled

Ortho-Clinical Diagnostics is recalling Vitros Chemistry Products Phyt Slides, distributed in Puerto Rico. The recall was initiated on 12 Jun 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUnique Identifier Number ( UDI) 10758750004690; This issue affects expired, current (in date) and future product GENs.
Quantity recalledUS; 4680; Foreign: 1286

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0273-2018
FDA event ID
77613
Recalling firm
Ortho-Clinical Diagnostics, Rochester, NY
Classification
Class II
Status
Terminated
Recall initiated
12 Jun 2017
FDA classified
22 Dec 2017
Reported
3 Jan 2018
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

12 Jun 2017Recall initiated by company
22 Dec 2017Classified by FDA+193 days
3 Jan 2018Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm identified the potential for biased results to be generated when processing VITROS PHYT Slide product with citrate plasma specimen samples. The current Instructions for Use (IFU) and Assay Summary Chart state serum, heparin plasma, and citrate plasma as acceptable specimen types for use with the PHYT assay.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

VITROS Chemistry Products PHYT Slides, REF/CATALOG 829 8671, Rx ONLY, IVD; Ortho-Clinical Diagnostics, Inc. For in vitro diagnostic use only. VITROS Chemistry Products PHYT Slides quantitatively measure phenytoin (PHYT) concentration in serum and plasma using VITROS 250/350/950/5,1 FS and 4600 Chemistry Systems and the VITROS 5600 Integrated System.

Where it was distributed

Worldwide Distribution - US Distribution including Puerto Rico and the following countries: Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico, Republic of Panama, Poland, Singapore, Spain, Russia and Venezuela.

Puerto Rico

Questions about this recall

Why was it recalled?

The firm identified the potential for biased results to be generated when processing VITROS PHYT Slide product with citrate plasma specimen samples. The current Instructions for Use (IFU) and Assay Summary Chart state serum, heparin plasma, and citrate plasma as acceptable specimen types for use with the PHYT assay.

Which lots are affected?

Unique Identifier Number ( UDI) 10758750004690; This issue affects expired, current (in date) and future product GENs.

Where was it sold?

Worldwide Distribution - US Distribution including Puerto Rico and the following countries: Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico, Republic of Panama, Poland, Singapore, Spain, Russia and Venezuela.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ortho-Clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656